Apatinib Promotes Apoptosis of Pancreatic Cancer Cells through Downregulation of Hypoxia-Inducible Factor-1α and Increased Levels of Reactive Oxygen Species
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apatinib Promotes Apoptosis of Pancreatic Cancer Cells through Downregulation of Hypoxia-Inducible Factor-1α and Increased Levels of Reactive Oxygen Species
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2019, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2019-02-05
DOI
10.1155/2019/5152072
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of HIF-1α inhibits the proliferation, migration and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression
- (2018) Jingjing Zhang et al. BIOSCIENCE REPORTS
- WITHDRAWN:Mitochondrial targeting of HIF-1α inhibits hypoxia-induced apoptosis independently of its transcriptional activity
- (2018) Hong-Sheng Li et al. FREE RADICAL BIOLOGY AND MEDICINE
- Apatinib concurrent gemcitabine for controlling malignant ascites in advanced pancreatic cancer patient
- (2017) Lijun Liang et al. MEDICINE
- Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review
- (2017) Cheng-Ming Li et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
- (2016) Giandomenico Roviello et al. CANCER LETTERS
- Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward
- (2016) Lorenzo Fornaro et al. JOURNAL OF CLINICAL ONCOLOGY
- Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Edward P. Balaban et al. JOURNAL OF CLINICAL ONCOLOGY
- Antiangiogenic therapy in oncology: current status and future directions
- (2016) Gordon C Jayson et al. LANCET
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Apatinib — new third-line option for refractory gastric or GEJ cancer
- (2016) Toru Aoyama et al. Nature Reviews Clinical Oncology
- Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer
- (2016) Pavan P. Adiseshaiah et al. Nature Reviews Clinical Oncology
- Apatinib for the treatment of gastric cancer
- (2016) Giandomenico Roviello et al. Expert Review of Gastroenterology & Hepatology
- ROS and Autophagy: Interactions and Molecular Regulatory Mechanisms
- (2015) Lulu Li et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Expression and significance of HIF-1α and HIF-2α in pancreatic cancer
- (2015) Min Wang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Autophagy, a double-edged sword in anti-angiogenesis therapy
- (2015) Jiatao Liu et al. MEDICAL ONCOLOGY
- The Regulation of the Autophagic Network and Its Implications for Human Disease
- (2014) Jing Yang et al. International Journal of Biological Sciences
- GDNF increases cell motility in human colon cancer through VEGF–VEGFR1 interaction
- (2013) Ssu-Ming Huang et al. ENDOCRINE-RELATED CANCER
- Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
- (2013) Sampurna Chatterjee et al. JOURNAL OF CLINICAL INVESTIGATION
- Simultaneous determination of apatinib and its four major metabolites in human plasma using liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study
- (2012) Juefang Ding et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
- (2011) Shu Tian et al. CANCER SCIENCE
- An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer
- (2011) Edward Chu Clinical Colorectal Cancer
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
- (2010) Jin Li et al. BMC CANCER
- An overview of small-molecule inhibitors of VEGFR signaling
- (2009) S. Percy Ivy et al. Nature Reviews Clinical Oncology
- Autophagy in the Pathogenesis of Disease
- (2008) Beth Levine et al. CELL
- Autophagy fights disease through cellular self-digestion
- (2008) Noboru Mizushima et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search